Show simple item record

dc.contributor.advisorRagin, Camille
dc.creatorJones, Gieira Shaquae
dc.date.accessioned2020-10-26T19:19:41Z
dc.date.available2020-10-26T19:19:41Z
dc.date.issued2013
dc.identifier.urihttp://hdl.handle.net/20.500.12613/1552
dc.description.abstractHead and neck cancer (HNC) is one of the top ten cancers in the world, and is caused by tobacco use, alcohol consumption and Human Papillomavirus (HPV). HPV associated HNC patients have improved survival rates compared to non -HPV associated HNC patients. This improved survival is due to HPV- positive tumors favorable response to chemotherapy and radiation. The literature has shown that there is a racial disparity in survival rates between Caucasians and African Americans, with African Americans having poorer survival rates. The aim of this study is to determine if the racial disparity among HNC patients is due to a difference in HPV prevalence between races. HPV prevalence in HNC was assessed by a meta-analysis of published articles (30/247) that reported race specific HPV prevalence. We also conducted a pooled analysis in which authors that assessed HPV in HNC were invited to submit their datasets. Meta-pooled prevalence estimates revealed that 20% of African American HNC patients had HPV-positive tumors, compared to 44% in Caucasians. However for both African American HNC patients and Caucasian HNC patients there was low to moderate heterogeneity between the studies (Q-test p-value = p < 0.001, I2 = 18.87%, and p= 0.008. I2 =65.47% respectively). The prevalence of HPV in African Americans was 60% and in Caucasians it was 39%. African Americans had a risk of oropharyngeal cancer that was no different from Caucasians (OR: 1.38, 95% CI: 0.53-3.62) but had an increased risk of death from oropharyngeal cancer (HR: 2.39, 95% CI 1.03-5.55) compared to Caucasians. The results of the pooled analysis does not support the concept that African Americans HNC patients have a lower prevalence of HPV, but substantiates the notion that African Americans have worse survival than Caucasians. However, these are preliminary results as the pooled analysis is still being conducted, the inclusion of more datasets in the analysis could alter these preliminary findings.
dc.format.extent77 pages
dc.language.isoeng
dc.publisherTemple University. Libraries
dc.relation.ispartofTheses and Dissertations
dc.rightsIN COPYRIGHT- This Rights Statement can be used for an Item that is in copyright. Using this statement implies that the organization making this Item available has determined that the Item is in copyright and either is the rights-holder, has obtained permission from the rights-holder(s) to make their Work(s) available, or makes the Item available under an exception or limitation to copyright (including Fair Use) that entitles it to make the Item available.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectEpidemiology
dc.subjectHead and Neck Cancer
dc.subjectHuman Papillomavirus
dc.subjectOropharyngeal Cancer
dc.subjectRacial Disparity
dc.titleRACIAL DISPARITIES IN HUMAN PAPILLOMAVIRUS PREVALENCE IN HEAD AND NECK CANCER PATIENTS: AN INTERNATIONAL POOLED AND META-ANALYSIS
dc.typeText
dc.type.genreThesis/Dissertation
dc.contributor.committeememberNelson, Deborah B.
dc.contributor.committeememberDavey, Adam
dc.description.departmentPublic Health
dc.relation.doihttp://dx.doi.org/10.34944/dspace/1534
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.degreeM.S.
refterms.dateFOA2020-10-26T19:19:41Z


Files in this item

Thumbnail
Name:
Jones_temple_0225M_11465.pdf
Size:
1.674Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record